Related Experiment Video
Updated: May 24, 2026
Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture
Published on: May 8, 2018
Analysis of the clonal repertoire of gene-corrected cells in gene therapy
Anna Paruzynski1, Hanno Glimm, Manfred Schmidt
1Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581 and 460, Heidelberg, Germany.
Abstract:
Gene therapy-based clinical phase I/II studies using integrating retroviral vectors could successfully treat different monogenetic inherited diseases. However, with increased efficiency of this therapy, severe side effects occurred in various gene therapy trials. In all cases, integration of the vector close to or within a proto-oncogene contributed substantially to the development of the malignancies. Thus, the in-depth analysis of integration site patterns is of high importance to uncover potential clonal outgrowth and to assess the safety of gene transfer vectors and gene therapy protocols. The standard and nonrestrictive linear amplification-mediated PCR (nrLAM-PCR) in combination with high-throughput sequencing exhibits technologies that allow to comprehensively analyze the clonal repertoire of gene-corrected cells and to assess the safety of the used vector system at an early stage on the molecular level. It enables clarifying the biological consequences of the vector system on the fate of the transduced cell. Furthermore, the downstream performance of real-time PCR allows a quantitative estimation of the clonality of individual cells and their clonal progeny. Here, we present a guideline that should allow researchers to perform comprehensive integration site analysis in preclinical and clinical studies.
Insights
Gene therapy using integrating retroviral vectors can treat inherited diseases but carries risks. Analyzing vector integration sites with linear amplification-mediated PCR (nrLAM-PCR) and sequencing is crucial for assessing safety and preventing malignancies.
Area of Science:
- Gene Therapy
- Molecular Biology
- Oncology
Background:
- Integrating retroviral vectors have shown success in treating monogenetic diseases.
- However, vector integration near proto-oncogenes has led to severe side effects, including malignancies, in gene therapy trials.
- Thorough analysis of integration site patterns is essential for evaluating gene therapy safety.
Purpose of the Study:
- To present a guideline for comprehensive integration site analysis in gene therapy studies.
- To detail methods for assessing the safety of gene transfer vectors and protocols.
- To clarify the biological consequences of vector systems on transduced cells.
Main Methods:
- Utilizing standard and nonrestrictive linear amplification-mediated PCR (nrLAM-PCR).
- Employing high-throughput sequencing for comprehensive analysis of the clonal repertoire.
- Applying real-time PCR for quantitative estimation of clonality.
Main Results:
- nrLAM-PCR combined with high-throughput sequencing allows early-stage safety assessment at the molecular level.
- These methods enable comprehensive analysis of gene-corrected cell repertoires.
- Quantitative real-time PCR facilitates the assessment of clonal outgrowth and cell fate.
Conclusions:
- Integration site analysis is critical for identifying potential clonal outgrowth and assessing gene therapy safety.
- nrLAM-PCR and high-throughput sequencing provide powerful tools for molecular safety evaluation.
- This guideline supports researchers in conducting robust integration site analyses in preclinical and clinical settings.
